[ASND] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
18-Aug-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -10.33%
YoY- -85.59%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 18 28 280 434 444 372 1,043 -93.37%
PBT -22,876 -41,482 -34,361 -34,117 -30,743 -25,153 -16,426 24.78%
Tax -99 -107 -186 -240 -37 -14 22 -
NP -22,777 -41,375 -34,175 -33,877 -30,706 -25,139 -16,448 24.31%
Tax Rate - - - - - - - -
Total Cost 22,795 41,403 34,455 34,311 31,150 25,511 17,491 19.36%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -126,538.89 -147,767.86 -12,205.36 -7,805.76 -6,915.77 -6,757.80 -1,576.99 1775.35%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.55 -1.07 -0.92 -1.04 -0.94 -0.78 -0.51 5.17%
EPS Diluted -0.55 -1.07 -0.88 -1.04 -0.94 -0.78 -0.51 5.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.